Please note: AABB reserves the right to make updates to this program.
Tuesday, July 25, 2017 [Rescheduled from 02/09/17]
2:00 – 3:30 PM (ET) 7:00 – 8:30 PM (GMT)
Master Program Number: 109 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Transfusion Medicine (Hemovigilance)
Intended Audience: Technologists, Nurses, Managers/Supervisors, Laboratory Staff, Medical Directors, Students/Fellows, Residents
Teaching Level: Intermediate
Director/Moderator: Barbee Whitaker, PhD, Senior Director, Research, AABB, Bethesda, MD
Speakers: Kathleen Puca, MD, Blood Center of Wisconsin, Milwaukie, WI; Karen King, MD, Medical Director, Johns Hopkins Medical Institute, Baltimore, MD; Katharine Downes, MD, Medical Director, University Hospital, Cleveland, OH
After participating in this educational activity, participants should be able to:
- Describe two formats for reporting transfusion reactions.
- Create a process to improve recognition and reporting of suspected transfusion reactions.
- Discuss the value of communicating results of transfusion reaction evaluation to healthcare providers for patient care.
Transfusion reactions are often underreported and under-recognized. In addition, when recognized, approaches for reporting suspected reactions and the extent of testing vary among institutions. This program will describe the process for reporting, testing and follow-up of suspected transfusion reactions at three healthcare institutions. Discussion will include processes to potentially improve reporting by nurses of suspected reactions, formats for reporting reactions, algorithm to standardize testing, and communication of results of reaction evaluation to healthcare providers to promote optimal patient care.
| || ||
|Single Viewer: Live||
|Single Viewer: On-Demand||
|Group Viewing: Live||
|Group Viewing: On-Demand||
|Group Viewing: Live & On-Demand||